Literature DB >> 19597445

Medication-associated diethylene glycol mass poisoning: a review and discussion on the origin of contamination.

Joshua G Schier1, Carol S Rubin, Dorothy Miller, Dana Barr, Michael A McGeehin.   

Abstract

Diethylene glycol (DEG), an extremely toxic chemical, has been implicated as the etiologic agent in at least 12 medication-associated mass poisonings over the last 70 years. Why DEG mass poisonings occur remains unclear. Most reports do not contain detailed reports of trace-back investigations into the etiology. The authors, therefore, conducted a systematic literature review on potential etiologies of these mass poisonings. The current available evidence suggests that substitution of DEG or DEG-containing compounds for pharmaceutical ingredients results from: (1) deception as to the true nature of certain ingredients by persons at some point in the pharmaceutical manufacturing process, and (2) failure to adhere to standardized quality control procedures in manufacturing pharmaceutical products intended for consumers. We discuss existing guidelines and new recommendations for prevention of these incidents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597445     DOI: 10.1057/jphp.2009.2

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  10 in total

1.  Diethylene glycol in health products sold over-the-counter and imported from Asian countries.

Authors:  Joshua G Schier; Dana B Barr; Zheng Li; Amy F Wolkin; Samuel E Baker; Lauren S Lewis; Michael A McGeehin
Journal:  J Med Toxicol       Date:  2011-03

2.  Long-term renal and neurologic outcomes among survivors of diethylene glycol poisoning.

Authors:  Laura Conklin; James J Sejvar; Stephanie Kieszak; Raquel Sabogal; Carlos Sanchez; Dana Flanders; Felicia Tulloch; Gerardo Victoria; Giselle Rodriguez; Nestor Sosa; Michael A McGeehin; Joshua G Schier
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

3.  Osmol gap method for the detection of diethylene glycol in human serum.

Authors:  Michael G Holland; Jamie Nelsen; Thomas G Rosano
Journal:  World J Emerg Med       Date:  2010

4.  Characterizing concentrations of diethylene glycol and suspected metabolites in human serum, urine, and cerebrospinal fluid samples from the Panama DEG mass poisoning.

Authors:  J G Schier; D R Hunt; A Perala; K E McMartin; M J Bartels; L S Lewis; M A McGeehin; W D Flanders
Journal:  Clin Toxicol (Phila)       Date:  2013-11-25       Impact factor: 4.467

Review 5.  Antidotes for poisoning by alcohols that form toxic metabolites.

Authors:  Kenneth McMartin; Dag Jacobsen; Knut Erik Hovda
Journal:  Br J Clin Pharmacol       Date:  2016-01-04       Impact factor: 4.335

6.  Neurotoxic effects of nephrotoxic compound diethylene glycol.

Authors:  Courtney N Jamison; Robert D Dayton; Brian Latimer; Mary P McKinney; Hannah G Mitchell; Kenneth E McMartin
Journal:  Clin Toxicol (Phila)       Date:  2021-01-21       Impact factor: 3.738

7.  COVID-19 and risks to the supply and quality of tests, drugs, and vaccines.

Authors:  Paul N Newton; Katherine C Bond
Journal:  Lancet Glob Health       Date:  2020-04-09       Impact factor: 26.763

8.  Follow-up of the re-evaluation of glycerol (E 422) as a food additive.

Authors:  Maged Younes; Gabriele Aquilina; Laurence Castle; Karl-Heinz Engel; Paul Fowler; Maria Jose Frutos Fernandez; Ursula Gundert-Remy; Rainer Gürtler; Trine Husøy; Melania Manco; Wim Mennes; Peter Moldeus; Sabina Passamonti; Romina Shah; Ine Waalkens-Berendsen; Detlef Wölfle; Matthew Wright; Karlien Cheyns; Manuela Mirat; Ana Maria Rincon; Peter Fürst
Journal:  EFSA J       Date:  2022-06-20

9.  A screening tool to prioritize public health risk associated with accidental or deliberate release of chemicals into the atmosphere.

Authors:  David H Blakey; Marc Lafontaine; Jocelyn Lavigne; Danny Sokolowski; Jean-Marc Philippe; Jean-Marc Sapori; Walter Biederbick; Regine Horre; Willi B Marzi; Hisayoshi Kondo; Yumiko Kuroki; Akira Namera; Tetsu Okumura; Miyako Yamamoto; Mikio Yashiki; Peter G Blain; David R Russell; Susan M Cibulsky; David A Jett
Journal:  BMC Public Health       Date:  2013-03-21       Impact factor: 3.295

Review 10.  Substandard drugs: a potential crisis for public health.

Authors:  Atholl Johnston; David W Holt
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.